Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|17|2917-2925

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.17, 2015-09, pp. : 2917-2925

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial

By Lin Chia-Chi   Hsu Chiun   Hsu Chih-Hung   Hsu Wei-Ling   Cheng Ann-Lii   Yang Chih-Hsin  

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 77-84

Springer Publishing Company

Access to resources Recommend Favorite

Arsenic trioxide in the treatment of haematological malignancies

By Kwong Yok-Lam  

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 589-597

Informa Healthcare

Access to resources Recommend Favorite

Arsenic trioxide for the treatment of myelodysplastic syndromes

By Vey Norbert  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 613-621

Informa Healthcare

Access to resources Recommend Favorite

Molecular Targeted Therapy of Hepatocellular Carcinoma - Results of the First Clinical Studies

By  

Current Cancer Drug Targets, Vol. 11, Iss. 6, 2011-07 ,pp. : 714-733

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment Modalities for Hepatocellular Carcinoma

By  

Current Cancer Drug Targets, Vol. 5, Iss. 2, 2005-03 ,pp. : 131-138

Bentham Science Publishers

Access to resources Recommend Favorite